“…Constitutive levels of CD59 originating from several types of cells and detected in biological fluids, may be an additional physiological mechanism of cellular protection against complement-mediated lysis in infection or inflammation [12]. Complement membrane regulators may be shed by erythrocytes and be reinserted into both homologous and heterologous cells, thus restricting lysis [21,22]. In vitro and in vivo studies have shown that GPI-anchored proteins can be transferred between cells in microvesicles or in high-density lipoprotein (HDL) particles [19], and it has been suggested that this mechanism could be of help in therapeutic processes such as the transfer of CD59 to the red cells of patients with paroxysmal nocturnal hemoglobinuria (PNH) [23].…”